Researchers Identify Biomarkers to Predict Patient Response to Immunotherapy Treatment for Melanoma
Wake Forest University School of MedicineResearchers at Wake Forest School of Medicine, led by David R. Soto-Pantoja, Ph.D., associate professor of surgery and cancer biology, have discovered blood biomarkers that can potentially predict patient response to immunotherapy in the treatment of melanoma.